Excited to share Created by Humans was featured in The New York Times for empowering authors in AI licensing & shaping the future of publishing! Check out the full feature and join the conversation: nytimes.com/2024/10/09/boo…

2024 has seen massive strides in 3D printed footwear & generative manufacturing! Explore how HILOS is driving the future of production with a bonus deep dive on whats coming in 2025! hilosphere.substack.com/p/2024-was-a-t…

🚀 Clay raises $40M in Series B expansion at a $1.25B valuation! With 6x growth in 2024, Clay is revolutionizing GTM with AI and 100+ integrations, helping teams find and activate customer data with unprecedented precision. 🔗 clay.com/blog/series-b-…

🚀 Continuing its acquisition spree, NeuroFlow acquires Quartet Health, expanding its AI-powered platform and enhancing its ability to scale integrated behavioral health for payers, health systems, and the federal government. 🔗neuroflow.com/neuroflow-acqu…

“…we’ve proven our ability to recreate complex genetic combinations that took nature millions of years to create.” Ben Lamm, CEO & Co Founder 🧬 Congrats to Colossal Biosciences®, for their recent TIME feature having achieved a monumental step for de-extinction time.com/7264043/coloss…

🚀 Exciting news! Upside x Marqeta to integrate personalized cash-back offers into consumer card programs to unlock new growth opportunities for consumer card programs. upside.com/newsroom/press…

🚀 Big shout to Clay named #1 in Mid-Stage on the Wing VC 2025 Enterprise Tech 30 List! Proud to see them leading in GTM innovation. See full list here: enterprisetech30.com

This isn't Jurassic Park, this is real life. Welcome (back) to the world: Remus & Romulus. 🐺🐺 Things will never be the same. 🧬 time.com/7274542/coloss…

The dire wolf is back; yes the real one, and Form Bio played a key role in making it happen! 🐺 Check out how their tech not only helped decode the wolf's ancient DNA, but is shaping drug discovery, rare disease research, and biodiversity conservation. newyorker.com/magazine/2025/…

The same genetic tools that revived the dire wolf are now cleaning up our oceans and landfills. Check out how Breaking is tackling the plastic crisis with X-32—a CRISPR-engineered microorganism with the potential to transform environmental restoration. newyorker.com/magazine/2025/…

🚀 UbiQD closes $20M Series B round to scale quantum dot tech, revolutionizing security, solar energy, greenhouse agriculture and other critical industries! 🔗 prnewswire.com/news-releases/…

Congrats to Puna Bio on securing a key Series A investment from Corteva Agriscience and others for sustainable agtech in LATAM! Their biological seed treatments are changing the game for food, cosmetics y mas! 🔗agtechnavigator.com/Article/2025/0…

🚀 Pathos secures $365M Series D, boosts valuation to $1.6B. New funding to accelerate the development of their AI-enabled oncology drug platform and progress their clinical-stage pipeline. Read more: axios.com/pro/biotech-de…

🚀 Congrats to Blank Beauty on raising $6.5M in Series A! We're proud to have supported Blank Beauty from the seed stage and are excited to see their continued growth and innovation in the beauty tech space. 🔗pulse2.com/blank-beauty-6…

🚀 Big news! Excited to welcome Mike Rosengarten as our new GP, leading enterprise & AI. From Ground Zero to Groundbreaking—welcome aboard, Mike. We’re just getting started! #BuildersVC #AI #startups

Congrats to Clay for closing their Series C at a $3B valuation! This round was led by CapitalG and will help fuel growth for the sales automation platform trusted by OpenAI, HubSpot and Canva to name drop a few. 👀 🔗 techcrunch.com/2025/06/13/cla…

Today marks the beginning of an exciting new era as SafeAI Autonomous Technology joins forces with Pronto to deliver one of the most flexible and scalable autonomy solutions in the industry, accelerating the future of autonomous construction and mining. 🔗 techcrunch.com/2025/07/15/av-…

Big news in the The New York Times today. @Clay_gtm just raised $100M at a $3.1B valuation to power today’s breakout AI-native job: GTM engineering 🚀 While some may debate which jobs AI will automate, we've been busy creating a new one that puts human creativity at the center. GTM

🚀 Big news from Clay! The team just raised $100M in Series C funding led by CapitalG with participation from Meritech Capital Partners and Sequoia Capital, bringing their valuation to $3.1B to scale the breakout AI-native career: GTM engineering nytimes.com/2025/08/05/bus…

🚀 Excited to welcome Michelle Chen, PhD as CEO & President of Form Bio! With Michelle at the helm, she’ll lead the next chapter in AI-powered genetic medicine & genome engineering, pushing the boundaries of AI-powered therapeutics. Full Release🔗 accessnewswire.com/newsroom/en/co…